SFRP2 and cirrhosis of liver: SFRP2 promoter methylation level was analyzed in liver biopsy samples obtained from HCV-positive patients suffering from chronic hepatitis (n = 15) or liver cirrhosis (n = 13), without any concomitant tumorous growth on their livers.